You are here



Icelandic researchers have uncovered two novel genetic variants of atrial fibrillation (AFib), one of which could increase the risk of developing AFib for susceptible patients.

Despite encountering more short-term complications after transcatheter aortic valve replacement (TAVR), women have better long-term survival rates than men, according to a meta-analysis of 47,188 patients. However, they remain at greater risk for stroke.

Published online Oct. 17 in the Journal of the American College of Cardiology, the guidelines offer recommendations on when to use transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR) or neither—and when either technique may be appropriate.

In the past 10 years, Medicare has spent more than $1.5 billion in replacing seven types of defective heart devices, according to the HHS Office of the Inspector General. The same report said patients dished out $140 million in out-of-pocket costs.

The 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium kicks off in Denver in less than two weeks. In preparation, Gregg W. Stone, MD, co-director of medical research and education at the Cardiovascular Research Foundation, provided some expected highlights of this year’s session Oct. 16 during a press briefing.